Adare Pharma Solutions

How Adare Pharma Solutions is evolving to keep pace with changes in the industry.

Adare Pharma Solutions - Evolving to Meet the Future Needs of Customers

Oral solid dose capabilities and small molecule expertise

Recent and planned expansions in packaging, high potency, and controlled substances offerings as well as a new nitrosamine mitigation offering

Videos

Articles

When a large CDMO couldn’t give a mid-size pharma company the proper attention, Adare stepped in to help manufacture CTM batches and get their project to the clinic quickly.

Case Study: Meeting An Aggressive Go-To-Clinic Timeline

A discussion of the FDA's guidance on nitrosamine impurities, various approaches for reducing the presence of impurities, and how Adare's unique nitrosamine mitigation process can help products achieve compliance.

Nitrosamine Impurities Deadline: Are You Compliant?

In this article, gain insights into how early-stage pharmaceutical product development is foundational for successful clinical trials and regulatory approvals, and why collaboration with experienced partners like CDMOs is essential.

Streamline Early-Stage Development to Reach the Clinic Faster

To help improve adherence in children, drug developers need to consider innovative new dosage forms that can deliver flexible and convenient medications for young patients.


Overcoming The Challenges Of Pediatric Formulation

Pediatric formulations have become increasingly important as the healthcare field recognizes the huge impact that strict patient adherence can have on a treatment’s efficacy. But to overcome the challenges of adherence in children, drug developers need to consider innovative new dosage forms that can deliver flexible and convenient medications for young patients.